{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:05:53Z","timestamp":1775581553047,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1053\/j.ajkd.2022.04.007","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T21:28:23Z","timestamp":1654118903000},"page":"473-482.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Clinical Response\u2013Adjusted Steroid Treatment Protocol for Children With Newly Diagnosed Idiopathic Nephrotic Syndrome"],"prefix":"10.1053","volume":"80","author":[{"given":"Elena","family":"Zion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Borovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadas","family":"Alfandary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orly","family":"Haskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoval","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Davidovits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ajkd.2022.04.007_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2008-1559","article-title":"Management of childhood onset nephrotic syndrome","volume":"124","author":"Gipson","year":"2009","journal-title":"Pediatrics"},{"issue":"9384","key":"10.1053\/j.ajkd.2022.04.007_bib2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ajkd.2022.04.007_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00467-018-3963-x","article-title":"Treating the idiopathic nephrotic syndrome: are steroids the answer?","volume":"34","author":"Desch\u00eanes","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2022.04.007_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01956754","article-title":"Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie","volume":"152","author":"Ehrich","year":"1993","journal-title":"Eur J Pediatr"},{"issue":"5","key":"10.1053\/j.ajkd.2022.04.007_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children","volume":"8","author":"Tarshish","year":"1997","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2022.04.007_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","article-title":"Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2022.04.007_bib7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0272-6386(03)00346-9","article-title":"A\u00a0randomized study of two long-course prednisolone regimens for nephrotic syndrome in children","volume":"41","author":"Hiraoka","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.007_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.2014.240","article-title":"Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome","volume":"87","author":"Sinha","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.007_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.2012070646","article-title":"Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome","volume":"24","author":"Teeninga","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.007_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.2014.260","article-title":"A\u00a0multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment","volume":"87","author":"Yoshikawa","year":"2015","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2022.04.007_bib11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00467-015-3106-6","article-title":"Corticosteroids for the initial episode of steroid-sensitive nephrotic syndrome","volume":"30","author":"Hodson","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2022.04.007_bib12","doi-asserted-by":"crossref","first-page":"l1800","DOI":"10.1136\/bmj.l1800","article-title":"Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation","volume":"365","author":"Webb","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"10.1053\/j.ajkd.2022.04.007_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jpeds.2009.12.020","article-title":"Time for initial response to steroids is a major prognostic factor in idiopathic nephrotic syndrome","volume":"156","author":"Vivarelli","year":"2010","journal-title":"J\u00a0Pediatr"},{"issue":"12","key":"10.1053\/j.ajkd.2022.04.007_bib14","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00467-008-0914-y","article-title":"Prediction of high-degree steroid dependency in pediatric idiopathic nephrotic syndrome","volume":"23","author":"Letavernier","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2022.04.007_bib15","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s004670100024","article-title":"Risk factors for steroid dependency in children with idiopathic nephrotic syndrome","volume":"16","author":"Yap","year":"2001","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2022.04.007_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1542\/peds.105.3.492","article-title":"Predicting first-year relapses in children with nephrotic syndrome","volume":"105","author":"Constantinescu","year":"2000","journal-title":"Pediatrics"},{"issue":"4","key":"10.1053\/j.ajkd.2022.04.007_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00467-012-2365-8","article-title":"Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome","volume":"28","author":"Harambat","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2022.04.007_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s004670050489","article-title":"Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome","volume":"12","author":"Kabuki","year":"1998","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2022.04.007_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00467-010-1537-7","article-title":"Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome","volume":"25","author":"Andersen","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"8632","key":"10.1053\/j.ajkd.2022.04.007_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(89)91266-X","article-title":"Nephrotic syndrome: from toddlers to twenties","volume":"1","author":"Lewis","year":"1989","journal-title":"Lancet"},{"issue":"9","key":"10.1053\/j.ajkd.2022.04.007_bib21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00467-018-3975-6","article-title":"Induction prednisone dosing for childhood nephrotic syndrome: how low should we go?","volume":"33","author":"Sibley","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2022.04.007_bib22","article-title":"Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children","volume":"4","author":"Larkins","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1053\/j.ajkd.2022.04.007_bib23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2215\/CJN.05950809","article-title":"Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome","volume":"4","author":"Niaudet","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2022.04.007_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/20469047.2017.1374003","article-title":"Nephrotic syndrome in infants and children: pathophysiology and management","volume":"37","author":"Downie","year":"2017","journal-title":"Paediatr Int Child Health"},{"issue":"8","key":"10.1053\/j.ajkd.2022.04.007_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00467-003-1176-3","article-title":"Long-term linear growth of children with severe steroid-responsive nephrotic syndrome","volume":"18","author":"Emma","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2022.04.007_bib26","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/ndt\/gfq097","article-title":"Behavioural abnormalities in children with nephrotic syndrome","volume":"25","author":"Mishra","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2022.04.007_bib27","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2215\/CJN.05691108","article-title":"Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children","volume":"4","author":"Kyrieleis","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2022.04.007_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5414\/CN108044","article-title":"Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood","volume":"81","author":"Skrzypczyk","year":"2014","journal-title":"Clin Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2022.04.007_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s004670050708","article-title":"Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome","volume":"13","author":"Bagga","year":"1999","journal-title":"Pediatr Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638622007053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638622007053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:44:35Z","timestamp":1759463075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638622007053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0272638622007053"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.04.007","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Clinical Response\u2013Adjusted Steroid Treatment Protocol for Children With Newly Diagnosed Idiopathic Nephrotic Syndrome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}